tizanidine

Product NDC
10544-576
11-digit product format
105440576
Labeler code
10544
Product ID
10544-576_9eb17a92-feec-42ce-b7ca-86367e164cc8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tizanidine
Dosage form
TABLET
Route
ORAL
Labeler
Blenheim Pharmacal, Inc.
Application
ANDA076533
Marketing category
ANDA
Marketing start
2014-01-22
Marketing end
0000-00-00
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a0ff02d8-b711-423c-b7d1-ada00d81c743Product name120250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01Product name820250313
b404127e-1c01-47bb-874e-db1e0b6bd9afProduct name420250313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10544-576-022019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-202019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-302019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-552019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-602019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-812019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-842019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996
10544-576-902019-11-27C16284748780-19855e2a2-3e64-60a7-e053-dbdaa90a05bdThese highlights do not include all the information needed to use tizanidine safely and effectively. See full prescribing information for tizanidine. TIZANIDINE tablets, USP for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10544-576-02tizanidine120 in 1 BOTTLETABLET1202
10544-576-20tizanidine20 in 1 BOTTLETABLET202
10544-576-30tizanidine30 in 1 BOTTLETABLET302
10544-576-55tizanidine150 in 1 BOTTLETABLET1502
10544-576-60tizanidine60 in 1 BOTTLETABLET602
10544-576-81tizanidine180 in 1 BOTTLETABLET1802
10544-576-84tizanidine84 in 1 BOTTLETABLET842
10544-576-90tizanidine90 in 1 BOTTLETABLET902

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10544-576TIZANIDINE TABLET [BLENHEIM PHARMACAL, INC.]2Legacy NDC, 8 package rows20140801_4e2fd72f-4e76-411c-9ab8-441547141b34.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313413tiZANidine HCl 4 MG Oral TabletPSN4e2fd72f-4e76-411c-9ab8-441547141b342
313413tizanidine 4 MG Oral TabletSCD4e2fd72f-4e76-411c-9ab8-441547141b342
313413tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral TabletSY4e2fd72f-4e76-411c-9ab8-441547141b342

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
10544-576-0210544057602120 in 1 BOTTLEHistorical
10544-576-201054405762020 in 1 BOTTLEHistorical
10544-576-301054405763030 in 1 BOTTLEHistorical
10544-576-5510544057655150 in 1 BOTTLEHistorical
10544-576-601054405766060 in 1 BOTTLEHistorical
10544-576-8110544057681180 in 1 BOTTLEHistorical
10544-576-841054405768484 in 1 BOTTLEHistorical
10544-576-901054405769090 in 1 BOTTLEHistorical